205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-10.32%
Revenue decline while MRVL shows 4.29% growth. Joel Greenblatt would examine competitive position erosion.
-8.84%
Cost reduction while MRVL shows 4.77% growth. Joel Greenblatt would examine competitive advantage.
-13.87%
Gross profit decline while MRVL shows 3.82% growth. Joel Greenblatt would examine competitive position.
-3.96%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-3.29%
R&D reduction while MRVL shows 1.74% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.47%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-6.72%
Total costs reduction while MRVL shows 2.65% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
85.45%
D&A growth above 1.5x MRVL's 1.23%. Michael Burry would check for excessive investment.
-72.60%
EBITDA decline while MRVL shows 4.17% growth. Joel Greenblatt would examine position.
-69.45%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-51.78%
Operating income decline while MRVL shows 15.99% growth. Joel Greenblatt would examine position.
-46.23%
Operating margin decline while MRVL shows 5.31% growth. Joel Greenblatt would examine position.
-106.82%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-61.67%
Pre-tax income decline while MRVL shows 8.06% growth. Joel Greenblatt would examine position.
-57.26%
Pre-tax margin decline while MRVL shows 3.62% growth. Joel Greenblatt would examine position.
-79.22%
Tax expense reduction while MRVL shows 9600.00% growth. Joel Greenblatt would examine advantage.
-53.37%
Both companies show declining income. Martin Whitman would check industry conditions.
-48.01%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-49.18%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-49.18%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
0.03%
Share count increase while MRVL reduces shares. John Neff would investigate differences.
0.23%
Diluted share reduction exceeding 1.5x MRVL's 1.17%. David Dodd would verify capital allocation.